180 related articles for article (PubMed ID: 12183250)
1. Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine.
Piret J; Roy S; Gagnon M; Landry S; Désormeaux A; Omar RF; Bergeron MG
Antimicrob Agents Chemother; 2002 Sep; 46(9):2933-42. PubMed ID: 12183250
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.
Piret J; Lamontagne J; Bestman-Smith J; Roy S; Gourde P; Désormeaux A; Omar RF; Juhász J; Bergeron MG
J Clin Microbiol; 2000 Jan; 38(1):110-9. PubMed ID: 10618073
[TBL] [Abstract][Full Text] [Related]
3. Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.
Roy S; Gourde P; Piret J; Désormeaux A; Lamontagne J; Haineault C; Omar RF; Bergeron MG
Antimicrob Agents Chemother; 2001 Jun; 45(6):1671-81. PubMed ID: 11353610
[TBL] [Abstract][Full Text] [Related]
4. Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.
Piret J; Désormeaux A; Cormier H; Lamontagne J; Gourde P; Juhász J; Bergeron MG
Antimicrob Agents Chemother; 2000 Sep; 44(9):2263-70. PubMed ID: 10952566
[TBL] [Abstract][Full Text] [Related]
5. Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment.
Bestman-Smith J; Piret J; Désormeaux A; Tremblay MJ; Omar RF; Bergeron MG
Antimicrob Agents Chemother; 2001 Aug; 45(8):2229-37. PubMed ID: 11451679
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of docusate as protective agent from herpes simplex viruses.
Gong Y; Wen A; Cheung D; Wong M; Sacks SL
Antiviral Res; 2001 Oct; 52(1):25-32. PubMed ID: 11530185
[TBL] [Abstract][Full Text] [Related]
7. Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses.
Piret J; Désormeaux A; Bergeron MG
Curr Drug Targets; 2002 Feb; 3(1):17-30. PubMed ID: 11899262
[TBL] [Abstract][Full Text] [Related]
8. Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands.
Bag P; Chattopadhyay D; Mukherjee H; Ojha D; Mandal N; Sarkar MC; Chatterjee T; Das G; Chakraborti S
Virol J; 2012 May; 9():98. PubMed ID: 22624581
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
Isaacs CE; Wen GY; Xu W; Jia JH; Rohan L; Corbo C; Di Maggio V; Jenkins EC; Hillier S
Antimicrob Agents Chemother; 2008 Mar; 52(3):962-70. PubMed ID: 18195068
[TBL] [Abstract][Full Text] [Related]
10. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
[TBL] [Abstract][Full Text] [Related]
11. Effect of black tea extract on herpes simplex virus-1 infection of cultured cells.
Cantatore A; Randall SD; Traum D; Adams SD
BMC Complement Altern Med; 2013 Jun; 13():139. PubMed ID: 23777309
[TBL] [Abstract][Full Text] [Related]
12. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice.
Donalisio M; Quaranta P; Chiuppesi F; Pistello M; Cagno V; Cavalli R; Volante M; Bugatti A; Rusnati M; Ranucci E; Ferruti P; Lembo D
Biomaterials; 2016 Apr; 85():40-53. PubMed ID: 26854390
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic Inactivation of Herpes Simplex Viruses.
Monjo AL; Pringle ES; Thornbury M; Duguay BA; Monro SMA; Hetu M; Knight D; Cameron CG; McFarland SA; McCormick C
Viruses; 2018 Sep; 10(10):. PubMed ID: 30274257
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide.
Pinna D; Oreste P; Coradin T; Kajaste-Rudnitski A; Ghezzi S; Zoppetti G; Rotola A; Argnani R; Poli G; Manservigi R; Vicenzi E
Antimicrob Agents Chemother; 2008 Sep; 52(9):3078-84. PubMed ID: 18573926
[TBL] [Abstract][Full Text] [Related]
16. Theaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.
Isaacs CE; Xu W
Antimicrob Agents Chemother; 2013 Aug; 57(8):3806-14. PubMed ID: 23716050
[TBL] [Abstract][Full Text] [Related]
17. Potential antiviral agents of Rosmarinus officinalis extract against herpes viruses 1 and 2.
Al-Megrin WA; AlSadhan NA; Metwally DM; Al-Talhi RA; El-Khadragy MF; Abdel-Hafez LJM
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469389
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
[TBL] [Abstract][Full Text] [Related]
19. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
[TBL] [Abstract][Full Text] [Related]
20. β-Carboline derivatives as novel antivirals for herpes simplex virus.
Gonzalez MM; Cabrerizo FM; Baiker A; Erra-Balsells R; Osterman A; Nitschko H; Vizoso-Pinto MG
Int J Antimicrob Agents; 2018 Oct; 52(4):459-468. PubMed ID: 30006037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
